Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Dydrogesterone for Luteal Phase Support in Natural Cycle FET
NCT03859921Phase 3Recruiting
- Sponsor
- The University of Hong Kong
- Start
- Jul 2021
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in infertility comparing Dydrogesterone with Placebo (2 arms). Primary endpoint: Live birth rate at 10 months. Started Jul 2021; status: recruiting.
02
Drugs
dydrogesterone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03859921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03859921.